Study Tests Potential Herpes Vaccine
A study now underway at the University of Alabama at Birmingham (UAB) aims to determine if an experimental vaccine is safe and effective in preventing genital herpes in young women.
The study marks the final phase of testing for the candidate vaccine called HERPEVAC developed by GlaxoSmithKline (GSK).
"If proven effective, it will be the first vaccine for a sexually transmitted disease," says Edward Hook, MD, professor of medicine at UAB.
Nationally, 26 sites are participating in the study directed by the National Institute of Allergy and Infectious Diseases and GSK. In total, sites will enroll 7,500 women between the ages of 18 and 30 who do not have oral or genital herpes. UAB will enroll 500 volunteers.
Source: University of Alabama at Birmingham
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care
May 5th 2025Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.
